Antonio Gambardella

Dr. Gambardella is a clinical neurologist and clinical researcher with a special interest in establishing close research links with basic scientists. His group, together with molecular genetic collaborators in Italy, discovered in 2000 the beta2 nicotinic acetylcholine receptor gene for nocturnal frontal lobe epilepsy and subsequently have been involved in the discovery of other epilepsy genes. A more recent important scientific result was the discovery of novel gene KCNT1 associated with a severe form of progressive myoclonus epilepsy. He has also focused on clinical, neurophysiological and neuroimaging aspects, and genetics of temporal lobe epilepsy, the most common type of focal epilepsy.